(XDJP) Nikkei 225 1D - Overview
Etf: Equity, Stock, Japan, Index, Replication
Dividends
| Dividend Yield | 1.52% |
| Yield on Cost 5y | 1.74% |
| Yield CAGR 5y | 9.72% |
| Payout Consistency | 86.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.4% |
| Relative Tail Risk | -3.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 17.89 |
| Character TTM | |
|---|---|
| Beta | 0.250 |
| Beta Downside | 0.407 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.18% |
| CAGR/Max DD | 0.93 |
Description: XDJP Nikkei 225 1D January 26, 2026
The Xtrackers Nikkei 225 UCITS ETF 1D (XETRA: XDJP) seeks to mirror the performance of the Nikkei Stock Average Index, which tracks 225 highly liquid Japanese large-cap stocks listed on the Tokyo Stock Exchange First Section. The index is rebalanced periodically based on five-year trading-volume and price-volatility metrics to preserve liquidity and reflect sector-level shifts, and the fund aims to hold the constituent shares in the same weightings as the index, managed by Deutsche Asset Management (UK) Limited.
As of 25 January 2026, the ETF carries an expense ratio of 0.25 % and manages roughly €1.2 billion in assets, with a 30-day tracking error of 0.12 % versus the Morningstar Japan TME NR JPY benchmark. The Nikkei has posted a +4.2 % year-to-date return, driven largely by a rebound in technology (≈30 % of index weight) and consumer-discretionary (≈20 %) sectors, while a weaker yen (≈¥155 per USD) continues to boost export-oriented earnings. Recent macro-drivers include the Bank of Japan’s shift toward a more flexible monetary stance and Japan’s Q4 2025 GDP growth estimate of 1.1 % YoY, both of which support corporate profit outlooks.
For a deeper quantitative comparison, you might explore ValueRay’s cross-ETF analytics to see how XDJP stacks up against peer Japan-focused funds.
What is the price of XDJP shares?
Over the past week, the price has changed by +3.50%, over one month by +6.44%, over three months by +6.58% and over the past year by +23.89%.
Is XDJP a buy, sell or hold?
What are the forecasts/targets for the XDJP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.3 | 15.9% |
XDJP Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 298.70b EUR (298.70b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 298.70b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 298.70b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.84% (E(298.70b)/V(298.70b) * Re(6.84%) + (debt-free company))
Discount Rate = 6.84% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)